Published On: Wed, Oct 19th, 2016

ITI Inc (NASDAQ:ITCI) – Broker Update

Below are the most recently updated broker updates which include ratings and price targets for ITI Inc (NASDAQ:ITCI).

10/11/2016 – Broker: Piper Jaffray Rating: overweight New Target: 22 reiteration

09/29/2016 – Broker: RBC Capital Rating: outperform New Target: 49 reiteration

09/29/2016 – Broker: SunTrust Rating: neutral New Target: 15 downgrade

09/29/2016 – Broker: JMP Securities Rating: market perform downgrade

09/29/2016 – Broker: Leerink Swann Rating: outperform New Target: 29 reiteration

09/29/2015 – Broker: Guggenheim Rating: buy New Target: 104 reiteration

09/17/2015 – Broker: Ladenburg Thalmann Rating: buy New Target: 75 reiteration

09/17/2015 – Broker: Cowen Rating: outperform New Target: 75 reiteration

The average price target from the most recent broker reports is 52.71

The stock decreased -0.98% (-0.13) during the last days session, reaching 13.12 and roughly 615527 shares were bought or sold by traders. ITI Inc (NASDAQ:ITCI) has decreased by -70.13% over 12 months.

ITI Inc. is a United States-based company. The Company is a subsidiary of Intra-Cellular Therapies Inc.